General Announcement::TMC Life Sciences Bhd announces Unaudited Interim Financial Report for the Quarter Ended 30 Nov 2018

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED GRP LTD W190424 - SG5HB3000007 - CSIW
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
25-Jan-2019 18:36:06
Status
New
Announcement Sub Title
TMC Life Sciences Bhd announces Unaudited Interim Financial Report for the Quarter Ended 30 Nov 2018
Announcement Reference
SG190125OTHR24IQ
Submitted By (Co./ Ind. Name)
Lim Hoi Leong
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attached Unaudited Interim Financial Report for the Financial Quarter Ended 30 November 2018 of TMC Life Sciences Berhad.

Attachments

TMCLS - Results announcement-Q12019.pdf
Total size =249K